PhRMA Urges Full Fed. Circ. To Walk Back New Venue Limits
The Pharmaceutical Research and Manufacturers of America is urging the full Federal Circuit to override a panel decision limiting where Hatch-Waxman Act patent suits can be filed, saying the ruling will...To view the full article, register now.
Already a subscriber? Click here to view full article